1
0
0
News
Standpunkt • Biotech | BioRegio STERN | Thinking business...
www.bioregio-stern.de
7. Juni · Dr. Mathias Bädeker, Senior Director Biopharma R&D bei der Boston Consulting Group berichtet über den Umsatz von Biopharmazeutika und die Steigerung der durchschnittlichen Zulassungszahlen in diesem Bereich
Standpoint • Biotech 2024BioRegio STERN
www.bioregio-stern.de
The participants of the panel discussion from left to right: Pablo Kimmig, Dr. Mathias Bädeker, Dr. Klaus Eichenberg, Dr. Dirk Biskup, Dominik Maurer, Ph.D. The participants of the panel discussion from left to right: Pablo Kimmig, Dr. Mathias Bädeker, Dr. Klaus Eichenberg, Dr. Dirk Biskup, Dominik Maurer, Ph.D.
Netzwerk-Profile
LinkedIn: Mathias Bädeker – Senior Knowledge Expert Biopharma R&D ...
Sehen Sie sich das Profil von Mathias Bädeker auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 2 Jobs sind im Profil von Mathias Bädeker ...
LinkedIn: Mathias Bädeker | LinkedIn
Mathias Bädekers berufliches Profil anzeigen LinkedIn ist das weltweit größte ... Januar – Heute (5 Monate)München und Umgebung, Deutschland ...
Es fehlt: bertelsmann
Mathias Baedeker - Boston Consulting Group
www.bcg.com
Mathias Bädeker is a core member of Boston Consulting Group’s Health Care practice and the practice's global Scientist Network. He is BCG’s knowledge-team manager for biopharma R&D and biopharma corporate-development topics.
Interessen
Autocatalytic Peptide Cyclization during Chain Folding of ...Cell Press
www.cell.com
von M Baedeker · · Zitiert von: 88 — Mathias Baedeker. Mathias Baedeker. Affiliations. Institut für Organische Chemie und Biochemie, Albert-Ludwigs-Universität, D Freiburg im Breisgau ... von M Baedeker · · Zitiert von: 88 — Mathias Baedeker. Mathias Baedeker. Affiliations. Institut für Organische Chemie und Biochemie, Albert-Ludwigs-Universität, D Freiburg im Breisgau ...
Download Figures (PPT)Cell Press
www.cell.com
Mathias Baedeker, Georg E Schulz. Structure. Volume 10 Issue 1 Pages (January 2002). DOI: S (01) X. Figure 1. Structure Mathias Baedeker, Georg E Schulz. Structure. Volume 10 Issue 1 Pages (January 2002). DOI: S (01) X. Figure 1. Structure
Business-Profile
How the Pandemic Is Redefining Clinical DevelopmentResearchGate
www.researchgate.net
By Christoph Meier, Andrew Rodriguez, Asher Steene, and Mathias Baedeker ... Mathias Baedeker PhD is a senior knowledge expert based in BCG's Munich office. By Christoph Meier, Andrew Rodriguez, Asher Steene, and Mathias Baedeker ... Mathias Baedeker PhD is a senior knowledge expert based in BCG's Munich office.
Ausbildung
Inferring bifurcations between phenotypesKing's College London
kclpure.kcl.ac.uk
Scannell, Mathias Baedeker, and Ulrik. Schulze. Breaking Eroom's Law. Nature reviews. Drug discovery,. 19(12):833–834, [21] Mohammed AlQuraishi and ... Scannell, Mathias Baedeker, and Ulrik. Schulze. Breaking Eroom's Law. Nature reviews. Drug discovery,. 19(12):833–834, [21] Mohammed AlQuraishi and ...
Bücher
Федичев П. - Взломать старение. Почему теперь мы ...calameo.com
www.calameo.com
Mathias Baedeker, Michael Ringel & Ulrik Schulze. Value of FDA approvals: back to the recent average. Nature Reviews Drug Discovery. 07 January Mathias Baedeker, Michael Ringel & Ulrik Schulze. Value of FDA approvals: back to the recent average. Nature Reviews Drug Discovery. 07 January
Healthcare Finance: Modern Financial Analysis for ...google.com
books.google.com
... Mathias Baedeker, and Ulrik Schulze “Breaking Eroom's Law.” Nature Reviews Drug Discovery 19: 833–834. Scannell, Jack W., Alex Blanckley, Helen ...
The Cloud Revolution: How the Convergence of New ...google.de
books.google.de
... Mathias Baedeker, and Ulrik Schulze. “Breaking Eroom's Law.” Nature Reviews Drug Discovery 19, no. 12 (2020): 833–34. https://doi.org d
Dokumente zum Namen
The Inactivation of Histidine Ammonia-Lyase by l-Cysteine ...ACS Publications
pubs.acs.org
von JD Galpin · · Zitiert von: 17 — Mathias Baedeker, Georg E. Schulz. Structures of two histidine ammonia‐lyase modifications and implications for the catalytic mechanism ... von JD Galpin · · Zitiert von: 17 — Mathias Baedeker, Georg E. Schulz. Structures of two histidine ammonia‐lyase modifications and implications for the catalytic mechanism ...
Overexpression of a designed 2.2 kb gene of eukaryotic ...FEBS Press
febs.onlinelibrary.wiley.com
von M Baedeker · · Zitiert von: 107 — Mathias Baedeker, Georg E. Schulz*. Institut fu«r Organische Chemie und Biochemie, Albert-Ludwigs-Universita«t, AlbertstraMe 21, D Freiburg im Breisgau ... von M Baedeker · · Zitiert von: 107 — Mathias Baedeker, Georg E. Schulz*. Institut fu«r Organische Chemie und Biochemie, Albert-Ludwigs-Universita«t, AlbertstraMe 21, D Freiburg im Breisgau ...
AngewandteEurekaMag
eurekamag.com
— Mathias Baedeker for the fruitful collabo- ration on the X-ray crystal structure of HAL and for a plasmid of the modified PAL gene. We are — Mathias Baedeker for the fruitful collabo- ration on the X-ray crystal structure of HAL and for a plasmid of the modified PAL gene. We are ...
Overexpression of a designed 2.2 kb gene of FEBS PressFEBS Press
febs.onlinelibrary.wiley.com
von M Baedeker · · Zitiert von: 105 — Overexpression of a designed 2.2 kb gene of eukaryotic phenylalanine ammonia-lyase in Escherichia coli. Mathias Baedeker,. Mathias Baedeker. von M Baedeker · · Zitiert von: 105 — Overexpression of a designed 2.2 kb gene of eukaryotic phenylalanine ammonia-lyase in Escherichia coli. Mathias Baedeker,. Mathias Baedeker.
Wissenschaftliche Veröffentlichungen
Autocatalytic Peptide Cyclization during Chain Folding of ...ScienceDirect.com
www.sciencedirect.com
von M Baedeker · · Zitiert von: 88 — Autocatalytic Peptide Cyclization during Chain Folding of Histidine Ammonia-Lyase. Author links open overlay panel. Mathias Baedeker , Georg E Schulz. Show ... von M Baedeker · · Zitiert von: 88 — Autocatalytic Peptide Cyclization during Chain Folding of Histidine Ammonia-Lyase. Author links open overlay panel. Mathias Baedeker , Georg E Schulz. Show ...
Veröffentlichungen allgemein
Medizinische Biotechnologie in Deutschland VFA BioYUMPU
www.yumpu.com
— Mathias Bädeker, Senior Analyst in der Praxisgruppe. Health Care. Den Vertretern von vfa bio Frau Dr. Sab — Mathias Bädeker, Senior Analyst in der Praxisgruppe. Health Care. Den Vertretern von vfa bio Frau Dr. Sab ...
2020 FDA approvals: momentum kept despite COVID ResearchGate
www.researchgate.net
Request PDF | On Jan 15, 2021, Mathias Baedeker and others published FDA approvals: momentum kept despite COVID-19, but value falls | Find, ... Request PDF | On Jan 15, 2021, Mathias Baedeker and others published FDA approvals: momentum kept despite COVID-19, but value falls | Find, ...
2023 FDA approvals: unprecedented volume at moderate ...National Genomics Data Center
ngdc.cncb.ac.cn
Jan 17, 2024; FDA approvals: unprecedented volume at moderate value. Mathias Baedeker, Michael S Ringel, Clemens C Möller. Author Information. Jan 17, 2024; FDA approvals: unprecedented volume at moderate value. Mathias Baedeker, Michael S Ringel, Clemens C Möller. Author Information.
Video & Audio
Medizinische Biotechnologie in Deutschland weiter im Aufwind ...
www.bio-m.org
11. Juli · Dr. Georg Kääb (BioM), Dr. Mathias Bädeker (BCG), Dr. Frank Mathias & Dr. Sabine Sydow (beide: vfa bio), Prof. Horst Domdey (BioM) und Mario Henke (Roche Diagnostics) (v.l.n.r.) bei der Präsentation der aktuellen Zahlen aus der medizinischen Biotechnologie in Deutschland.
Artikel & Meinungen
2022 FDA approval number dips: a COVID-19 hangover?Nature
www.nature.com
Mathias Baedeker,; Michael S. Ringel,; Clemens C. Möller & … Ulrik Schulze. Show authors. Mathias Baedeker. Boston Consulting Group ... Mathias Baedeker,; Michael S. Ringel,; Clemens C. Möller & … Ulrik Schulze. Show authors. Mathias Baedeker. Boston Consulting Group ...
2020 FDA approvals: momentum kept despite COVID-19, ...Nature
www.nature.com
— FDA approvals: momentum kept despite COVID-19, but value falls. By; Mathias Baedeker,; Michael Ringel &; Ulrik Schulze. Mathias Baedeker — FDA approvals: momentum kept despite COVID-19, but value falls. By; Mathias Baedeker,; Michael Ringel &; Ulrik Schulze. Mathias Baedeker.
2023 FDA approvals: unprecedented volume at moderate ...Nature
www.nature.com
— Mathias Baedeker, · Michael S. Ringel & · Clemens C. Möller — Mathias Baedeker, · Michael S. Ringel & · Clemens C. Möller.
2017 FDA drug approvals: number rebounds but average ...Nature
www.nature.com
— Mathias Baedeker. The Boston Consulting Group, Exchange Place, 31st floor, BostonMassachusetts, USA. Michael Ringel & Valery Panier — Mathias Baedeker. The Boston Consulting Group, Exchange Place, 31st floor, BostonMassachusetts, USA. Michael Ringel & Valery Panier.
Sonstiges
Mathias Bädeker - Senior Knowledge Expert Biopharma R&D & ...Wiza
wiza.co
View Mathias Bädeker's email address () and phone number. Mathias works at Boston Consulting Group (Bcg) as Senior Knowledge Expert ... View Mathias Bädeker's email address () and phone number. Mathias works at Boston Consulting Group (Bcg) as Senior Knowledge Expert ...
2020 FDA approvals: momentum kept despite COVID Outbreak.info
outbreak.info
Mathias Baedeker,. Michael Ringel, and. Ulrik Schulze. view affiliations. Nature reviews. Drug discovery, volume 20, issue updated 11 February Mathias Baedeker,. Michael Ringel, and. Ulrik Schulze. view affiliations. Nature reviews. Drug discovery, volume 20, issue updated 11 February
2023 FDA approvals: unprecedented volume at moderate ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von M Baedeker — Mathias Baedeker, Michael S Ringel, Clemens C Möller. PMID: ; DOI: d No abstract available. Publication types. News. MeSH ... von M Baedeker — Mathias Baedeker, Michael S Ringel, Clemens C Möller. PMID: ; DOI: d No abstract available. Publication types. News. MeSH ...
2020 FDA drug approvals - RMIT University LibraryEx Libris Group
rmit.alma.exlibrisgroup.com
2020 FDA approvals: momentum kept despite COVID-19, but value falls. Mathias Baedeker Nature Reviews Drug Discovery.2021, Vol. 20(2), p Article FDA approvals: momentum kept despite COVID-19, but value falls. Mathias Baedeker Nature Reviews Drug Discovery.2021, Vol. 20(2), p Article ...
23 publicationsOUCI
ouci.dntb.gov.ua
Mathias Baedeker, Georg E. Schulz. Histidine ammonia‐lyase (EC ) catalyzes the nonoxidative elimination of the α‐amino group of histidine using a Mathias Baedeker, Georg E. Schulz. Histidine ammonia‐lyase (EC ) catalyzes the nonoxidative elimination of the α‐amino group of histidine using a
2021 年FDA 批准：由COVID-19 疫苗驱动的价值X-MOL
www.x-mol.com
Mathias Baedeker , Michael S. Ringel , Ulrik Schulze. Discover the world's best science and medicine | Nature.com 中文翻译： 年FDA 批准：由COVID-19 疫苗 ... Mathias Baedeker , Michael S. Ringel , Ulrik Schulze. Discover the world's best science and medicine | Nature.com 中文翻译： 年FDA 批准：由COVID-19 疫苗 ...
Sigma-Aldrich
www.sigmaaldrich.com
Mathias Baedeker et al. European journal of biochemistry, 269(6), ( ). Histidine ammonia-lyase (EC ) catalyzes the nonoxidative ... Mathias Baedeker et al. European journal of biochemistry, 269(6), ( ). Histidine ammonia-lyase (EC ) catalyzes the nonoxidative ...
Breaking Eroom's Law - Document - Gale Academic OneFileGale
go.gale.com
von MS Ringel · · Zitiert von: 84 — Author(s): Michael S. Ringel, Jack W. Scannell, Mathias Baedeker, Ulrik Schulze. von MS Ringel · · Zitiert von: 84 — Author(s): Michael S. Ringel, Jack W. Scannell, Mathias Baedeker, Ulrik Schulze.
EMI1 switches from being a substrate to an inhibitor of APC ...Leitir.is
leitir.is
Mathias Baedeker Nature reviews. Drug discovery.2018, Vol. 17(2), p Grein Stungið uppá af BX logo · FDA approvals for the first 6 months of Asher ... Mathias Baedeker Nature reviews. Drug discovery.2018, Vol. 17(2), p Grein Stungið uppá af BX logo · FDA approvals for the first 6 months of Asher ...
How the Pandemic Is Redefining Clinical DevelopmentBoston Consulting Group
www.bcg.com
How the Pandemic Is Redefining Clinical Development. September 11, By Chris Meier, Andrew Rodriguez, Asher Steene, and Mathias Bädeker. How the Pandemic Is Redefining Clinical Development. September 11, By Chris Meier, Andrew Rodriguez, Asher Steene, and Mathias Bädeker.
GENEDISCOOpenReview
openreview.net
von A Mehrjou · · Zitiert von: 16 — Michael S Ringel, Jack W Scannell, Mathias Baedeker, and Ulrik Schulze. Breaking eroom's law. Nature Reviews Drug Discovery, Dan Roth and Kevin Small ... von A Mehrjou · · Zitiert von: 16 — Michael S Ringel, Jack W Scannell, Mathias Baedeker, and Ulrik Schulze. Breaking eroom's law. Nature Reviews Drug Discovery, Dan Roth and Kevin Small ...
Medizinische Biotechnologie in Deutschland 2022DocPlayer.org
docplayer.org
... MATHIAS BÄDEKER MARKUS HILDINGER Boston Consulting Group. Alle Rechte vorbehalten Für Nachbestellungen und Nachdruckgenehmigungen wenden Sie sich bitte MATHIAS BÄDEKER MARKUS HILDINGER Boston Consulting Group. Alle Rechte vorbehalten Für Nachbestellungen und Nachdruckgenehmigungen wenden Sie sich bitte ...
Nature Reviews Drug DiscoveryMediLib
medilib.ir
2023 FDA approvals: unprecedented volume at moderate value. By Mathias Baedeker, Michael S. Ringel & Clemens C. Möller. doi : d خرید FDA approvals: unprecedented volume at moderate value. By Mathias Baedeker, Michael S. Ringel & Clemens C. Möller. doi : d خرید ...
Novel cofactors via post-translational modifications of ...Ex Libris Group
i-share-uiu.primo.exlibrisgroup.com
Mathias Baedeker Structure.2002, Vol. 10(1), p Article suggested by BX logo. ALTERNATIVE PACKING ARRANGEMENTS IN THE HYDROPHOBIC CORE OF LAMBDA ... Mathias Baedeker Structure.2002, Vol. 10(1), p Article suggested by BX logo. ALTERNATIVE PACKING ARRANGEMENTS IN THE HYDROPHOBIC CORE OF LAMBDA ...
R&D productivity: on the comeback trailOUCI
ouci.dntb.gov.ua
Authors: Ulrik Schulze, Mathias Baedeker, Yen Ting Chen, David Greber. List of references. Tollman, P. et al. Identifying R&D outliers. Nature Rev. Drug ... Authors: Ulrik Schulze, Mathias Baedeker, Yen Ting Chen, David Greber. List of references. Tollman, P. et al. Identifying R&D outliers. Nature Rev. Drug ...
Overexpression of a designed 2.2 kb gene of eukaryo...Research Solutions/Reprints Desk
articles.researchsolutions.com
Mathias Baedeker,Georg E Schulz,. FEBS Letters. Volume 457 Issue 1 Pages Year Get access to this article via: Choose your institution... PDF or ... Mathias Baedeker,Georg E Schulz,. FEBS Letters. Volume 457 Issue 1 Pages Year Get access to this article via: Choose your institution... PDF or ...
Synthetic Organic ChemistryPeeriodicals
peeriodicals.com
Scannell, Mathias Baedeker, Ulrik Schulze. PubMed: DOI: d Subjects. Content. About us; Contact us. Follow Us. Twitter. Legal. Scannell, Mathias Baedeker, Ulrik Schulze. PubMed: DOI: d Subjects. Content. About us; Contact us. Follow Us. Twitter. Legal.
Showing papers in "Nature Reviews Drug Discovery in 2023"AI Chat for scientific PDFs
typeset.io
... a COVID-19 hangover? Mathias Baedeker, Michael Ringel, Clemens C Möller, Ulrik Schulze. 12 Jan Nature Reviews Drug Discovery. Save. 1 · 2 · 3 · 4 … a COVID-19 hangover? Mathias Baedeker, Michael Ringel, Clemens C Möller, Ulrik Schulze. 12 Jan Nature Reviews Drug Discovery. Save. 1 · 2 · 3 · 4 … 5.
Valery Panier's Profile | Nature JournalistMuck Rack
muckrack.com
Mathias Baedeker, Valery Panier, Ulrik Schulze. | Nature Verified. The authors of this article are employees of The Boston Consulting Group (BCG), a ... Mathias Baedeker, Valery Panier, Ulrik Schulze. | Nature Verified. The authors of this article are employees of The Boston Consulting Group (BCG), a ...
Value of FDA approvals: back to the recent average.Gale
go.gale.com
von M Baedeker · · Zitiert von: 4 — Gale OneFile includes Value of FDA approvals: back to the recent average by Mathias Baedeker, Michael Ringel, and U. Click to explore. von M Baedeker · · Zitiert von: 4 — Gale OneFile includes Value of FDA approvals: back to the recent average by Mathias Baedeker, Michael Ringel, and U. Click to explore.
Verwandte Suchanfragen zu Mathias Bädeker
| Hans Brandstetter Anja Jestel Sofia Macieira | Chris Meier Claudio Klein Frank Bressau | Patrick Hübler |
Personen Vorname "Mathias" (19244) Name "Bädeker" (27) |
sortiert nach Relevanz / Datum